Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class ITerminatedJan 24, 2024Secret, Dry SprayChemical contamination: presence of benzeneThe Procter & Gamble Company · D-0244-2024Class ITerminatedJan 24, 2024Secret, Dry SprayChemical contamination: presence of benzeneThe Procter & Gamble Company · D-0243-2024Class ITerminatedJan 24, 2024Secret, powder freshChemical contamination: presence of benzeneThe Procter & Gamble Company · D-0242-2024Class ITerminatedJan 24, 2024Old SpiceChemical contamination: presence of benzeneThe Procter & Gamble Company · D-0241-2024Class ITerminatedJan 24, 2024Old SpiceChemical contamination: presence of benzeneThe Procter & Gamble Company · D-0240-2024Class IITerminatedJan 24, 2024Old SpiceCGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzeneThe Procter & Gamble Company · D-0239-2024Class ITerminatedJan 24, 2024Old SpiceChemical contamination: presence of benzeneThe Procter & Gamble Company · D-0238-2024Class IIOngoingJan 24, 2024Ibuprofen and Famotidine Tablets 800mg/26.6mgPresence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle of Ibuprofen and Famotidine.Ascend Laboratories, LLC · D-0237-2024Class ICompletedJan 24, 2024AmericaineChemical Contamination: presence of benzeneInsight Pharmaceuticals LLC, a Prestige Consumer Healthcare company · D-0236-2024Class IOngoingJan 24, 2024Atropine Sulfate InjectionPresence of Particulate Matter; identified as glassPfizer Inc. · D-0235-2024Class IOngoingJan 24, 20248.4 % Sodium Bicarbonate InjectionPresence of Particulate Matter; identified as glassPfizer Inc. · D-0234-2024Class IOngoingJan 24, 20244.2% Sodium Bicarbonate InjectionPresence of Particulate Matter; identified as glassPfizer Inc. · D-0233-2024Class IIOngoingJan 24, 2024VasostrictSuperpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.Par Sterile Products LLC · D-0232-2024Class IIOngoingJan 24, 2024Freskaro refresh & revitalize Magnesium Citrate Saline Laxative Oral Solution Cherry Flavor 10 fl. ozMICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.Pharma Nobis LLC · D-0231-2024Class IIOngoingJan 24, 2024Freskaro refresh & revitalize Magnesium Citrate Saline Laxative Oral Solution Grape Flavor 10 fl. ozMICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.Pharma Nobis LLC · D-0230-2024Class IIOngoingJan 24, 2024CVS Health Magnesium Citrate Saline Laxative Oral Solution DYE FREE Grape Flavor 10 fl. ozMICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.Pharma Nobis LLC · D-0229-2024Class IIOngoingJan 24, 2024Walgreens Dye-Free Magnesium Citrate Saline Laxative/Oral SolutionMICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.Pharma Nobis LLC · D-0228-2024Class IIOngoingJan 24, 2024Good Neighbor PharmacyMICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.Pharma Nobis LLC · D-0227-2024Class IICompletedJan 17, 2024Tizanidine TabletsPresence of Foreign tablets/capsules - identified as tizanidine 2 mg tablets.Dr. Reddy's Laboratories, Inc. · D-0223-2024Class IIOngoingJan 17, 2024buPROPion Hydrochloride Extended-Release TabletsPresence of Foreign Tablets/CapsulesRising Pharma Holding, Inc. · D-0222-2024Class IITerminatedJan 17, 2024Desloratadine Tablets USP 5mg a)CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.Lupin Pharmaceuticals Inc. · D-0221-2024Class ICompletedJan 17, 2024Vigabatrin for Oral SolutionDefective Container: powder may leak out of the pouchInvaGen Pharmaceuticals, Inc. · D-0220-2024Class IITerminatedJan 17, 2024Tacrolimus CapsulesPresence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.Dr. Reddy's Laboratories, Inc. · D-0219-2024Class IIOngoingJan 10, 2024DELFLEX Peritoneal Dialysis Solution in Biofine container 1.5% DextroseLack of Sterility AssuranceFresenius Medical Care Holdings, Inc. · D-0218-2024Class IIOngoingJan 10, 2024Quality Choice No Drip Severe Congestion Nasal Pump MistCGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final...Seaway Pharma Inc. · D-0217-2024Class IIOngoingJan 10, 2024Quality Choice No Drip Extra Moisturizing Nasal Pump Mist Oxymetazoline hydrochloride 0.05%CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final...Seaway Pharma Inc. · D-0216-2024Class IIOngoingJan 10, 2024Premier Value Tussin Cough DMCGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final...Seaway Pharma Inc. · D-0215-2024Class IIOngoingJan 10, 2024Nasal Spray Original No Drip Oxymetazoline HCl Nasal SolutionCGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final...Seaway Pharma Inc. · D-0214-2024Class IIITerminatedJan 10, 2024EprontiaFailed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18...Azurity Pharmaceuticals, Inc. · D-0213-2024Class IOngoingJan 3, 2024Sure Regular Antiperspirant Deodorant AerosolChemical contamination: Presence of benzeneTcp Hrb Acquisiton LLC · D-0209-2024Class IOngoingJan 3, 2024Sure Unscented Anti-perspirant Deodorant AerosolChemical contamination: Presence of benzeneTcp Hrb Acquisiton LLC · D-0208-2024Class IOngoingJan 3, 2024Brut Classic Antiperspirant & DeodorantChemical contamination: Presence of benzeneTcp Hrb Acquisiton LLC · D-0207-2024Class IOngoingJan 3, 2024Magnum XXL 9800Marketed without an approved NDA/ANDA: Magnum XXL found to contain undeclared active pharmaceutical ingredient (API) - Sildenafil.Meta Herbal · D-0206-2024Class IIOngoingJan 3, 2024Sertraline TabletsCGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.Legacy Pharmaceutical Packaging LLC · D-0205-2024Class IITerminatedJan 3, 2024Thiamine HCl/Pyridoxine HCl 20 mg/mL /100mg/ml Injection SolutionPresence of Particulate Matter.AnazaoHealth Corporation · D-0204-2024Class IITerminatedJan 3, 2024B-ComplexPresence of Particulate Matter.AnazaoHealth Corporation · D-0203-2024Class IITerminatedJan 3, 2024Inhub WixelaCGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.Cardinal Healthcare · D-0202-2024Class IITerminatedJan 3, 2024Warfarin Sodium TabletsCGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.Cardinal Healthcare · D-0201-2024Class IITerminatedJan 3, 2024Warfarin Sodium TabletsCGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.Cardinal Healthcare · D-0200-2024Class IITerminatedJan 3, 2024Triamterene and Hydrochlorothiazide CapsulesCGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.Cardinal Healthcare · D-0199-2024